LOG IN OR SIGN UP TO "MY Eu2P"Organization for risk management in the industry
OBJECTIVESThis course aims to define the general principles needed to build a process for developing Risk Management Plans for a medicinal product by the Industry. This course is based on the experience of a large international pharmaceutical company.
LEARNING OUTCOMESAt the end of the course, you will know the main principles for establishing a RMP process in a pharmaceutical company.
|
|
||||||||||||
AUTHORS
|
Dr. Katia Verhamme Erasmus Universitair Medisch Centrum |
|
Dr. Laurent Auclert Sanofi-aventis Recherche et Développement |
|
Prof. Annalisa Capuano Università degli Studi della Campania Luigi Vanvitelli |
|
Nasop Experts Group ISoP's North American chapter |
